Odunlade Olufunke, Adeodu Olugbenga, Owa Joshua, Obuotor Efere
University of Medical Sciences, Ondo, Nigeria.
Obafemi Awolowo University, Ile-Ife, Nigeria.
Hematol Transfus Cell Ther. 2019 Jul-Sep;41(3):216-221. doi: 10.1016/j.htct.2018.11.006. Epub 2019 Mar 28.
In this study, children with sickle cell anemia were evaluated for iron deficiency. Serum ferritin and free erythrocyte protoporphyrin free erythrocyte protoporphyrin (FEP) levels, mean corpuscular volume mean corpuscular volume (MCV) and mean corpuscular hemoglobin mean corpuscular hemoglobin (MCH) were used in determining their iron status. The study was done at Pediatric Hematology Outpatient Clinic of the Obafemi Awolowo University Teaching Hospitals' Complex, Ile-Ife. Forty-eight HbSS subjects in steady state and 48 apparently well age and sex matched HbAA controls were evaluated. Serum ferritin less than 25ng/dL FEP greater than cut off for age, mean corpuscular volume MCV and mean corpuscular hemoglobin MCH less than cut off for age were regarded as indicating iron deficiency. Serum ferritin values ranged from 34.2 to 3282.9μg/L, with a mean of 381.2 (1.0), median 180μg/L; which was significantly higher than the controls (p=0.000). FEP was lower in the subjects but none was iron deficient compared with the controls. The mean corpuscular hemoglobin MCH of subjects was significantly lower than the controls. Subjects had lower mean corpuscular volume MCV compared with controls. Iron deficiency was not detected in any of the subjects with sickle cell anemia in comparison to a prevalence of 43.75% in the controls. Iron deficiency anemia (IDA) was found in 16.7% of the controls, using the WHO cut off for anemia which is hemoglobin concentration of <11g/dl. While a high prevalence of iron deficiency was noted in the control group, patients with sickle cell anemia were largely iron sufficient, despite their anemia. Iron supplementation remains unnecessary as part of routine management of children with sickle cell anemia in our practice.
在本研究中,对镰状细胞贫血患儿进行了缺铁评估。血清铁蛋白、游离红细胞原卟啉(FEP)水平、平均红细胞体积(MCV)和平均红细胞血红蛋白(MCH)用于确定他们的铁状态。该研究在伊费奥巴费米·阿沃洛沃大学教学医院综合院区的儿科血液科门诊进行。对48名处于稳定状态的HbSS受试者和48名年龄、性别匹配且表面健康的HbAA对照者进行了评估。血清铁蛋白低于25ng/dL、FEP高于年龄截断值、平均红细胞体积(MCV)和平均红细胞血红蛋白(MCH)低于年龄截断值被视为缺铁的指标。血清铁蛋白值范围为34.2至3282.9μg/L,平均值为381.2(1.0),中位数为180μg/L;显著高于对照组(p = 0.000)。受试者的FEP较低,但与对照组相比无缺铁情况。受试者的平均红细胞血红蛋白(MCH)显著低于对照组。与对照组相比,受试者的平均红细胞体积(MCV)较低。与对照组43.75%的患病率相比,镰状细胞贫血受试者中未检测到缺铁情况。根据世界卫生组织贫血的截断值(血红蛋白浓度<11g/dl),对照组中16.7%的人患有缺铁性贫血(IDA)。虽然对照组中铁缺乏的患病率较高,但镰状细胞贫血患者尽管贫血,但大多铁充足。在我们的实践中,作为镰状细胞贫血患儿常规管理的一部分,补铁仍然没有必要。